Examination of changes in blood NAD and NMN concentration by oral intake of NMN

Effect of oral ingestion of NMN on blood NAD derivatives concentration - Effect on blood NAD derivatives concentration

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047042

Enrollment

Registered

2022-03-01

Start date

2022-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Men and women aged between 20 and 60 without critical diseases such as diabetes mellitus.

Interventions

After collecting the blood of volunteers, they ingest 250mg of NMN supplement a day for 12 weeks and collect blood every 4 weeks. Changes in blood NAD levels before and after ingestion of NMN are meas

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Healthy male and female volunteers 2. Between 20 and 70 years of age 3. Be able to provide written informed consent

Exclusion criteria

Exclusion criteria: With a critical disease such as diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Blood NAD level	—

Countries

Japan

Contacts

Public ContactTakuya Yamane

ByU-Analytica Inc. Division of Research and Development

yamane@byuanalytica.com06-6879-4177

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026